Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

November 25, 2015 7:34 PM ET

Healthcare Equipment and Supplies

Company Overview of SurModics, Inc.

Executive Profile

Gary R. Maharaj

Chief Executive Officer, President and Director, SurModics, Inc.
AgeTotal Calculated CompensationThis person is connected to 2 Board Members in 2 different organizations across 3 different industries.

See Board Relationships
As of Fiscal Year 2014


Mr. Gary R. Maharaj is the Chief Executive Officer and President at SurModics, Inc. since December 27, 2010. Mr. Maharaj was the Chief Executive Officer and President at Arizant Inc. He was the Vice President of Philip Adam and Associates, a product development management consulting firm, and in various management and research positions for the orthopedic and rehabilitation divisions of Smith & Nephew, PLC. He is the author of numerous technical articles on medical devices ...

Corporate Headquarters

9924 West 74th Street
Eden Prairie, Minnesota 55344

United States

Phone: 952-500-7000
Fax: 952-500-7001

Board Members Memberships

Chief Executive Officer, President and Director
Director, Member of Audit Committee and Member of Nominating/Corporate Governance Committee


Master's Degree
University of Texas Southwestern Medical Center - Dallas
University Of Texas At Arlington
Carlson School of Business University of Minnesota
The University of The West Indies, St. Augustine

Other Affiliations

Annual Compensation

Total Annual Compensation$443,700

Stocks Options

Restricted Stock Awards$325,000
All Other Compensation$5,974
Exercisable Options$92,015
Exercisable Options Value$515,444
Unexercisable Options$113,331
Unexercisable Options Value$290,903
Total Value of Options$806,347
Total Number of Options$205,346

Total Compensation

Total Annual Cash Compensation$707,375
Total Short Term Compensation$443,700
Other Long Term Compensation$330,974
Total Calculated Compensation$1,357,375

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


Leonard S. Schleifer M.D., Ph.D.Co-Founder, Chief Executive Officer, President, Executive Director and Ex-Officio Member of Technology Committee
Regeneron Pharmaceuticals, Inc.
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact SurModics, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at